Pharmacological Research. Vol. 21, Supplement 1,1989
87
EFFECT OF DOXORUBICIN ON CALCIUM RECEPTORS OF MYOCARDIAL CELLS E. Monti,
L.
Paracchini,
G. Perletti
tst. di Farmacologia, sez, Farmacologia Applicata, untv, di Milano Key words: Doxorubicin -
Calcium -
Previous investigations on Doxorubicin
(DXR)
in
slow channels - Protein kinase-C
the acute cardiotoxic effects induced by
mammals
showed
that
the
impairment
of
the
contractile force produced by ttle drug is related to the inhibition of the cellular calcium exchangeability, whereby the fast exchanging pool is mainly affected (1). the activity
of
This pharmacokinetic parameter is the sum of
numerous
enzymes and cellular
structures
(2);
the
identification of the action of DXR on the cellular calcium exchanges was tested on the Ca-ATPase and the sarcolemmal Na-Ca exchange, Which were found to be inhibited by DXR (3, 4). In the present investigation we studied the effect of DXR on different cellular calcium targets, namely
the
(CaM) and
sarcolemmal
voltage-operated
channels
(VOC),
Calmodulin
Protein Kinase-C (PKC).
voc-enr-cnec
preparations were obtained from rat heart, PKC was iso-
lated from rat brain, commerCial CaM was used. The effect of DXR on VOC and CaM was evaluated by binding experiments using 3H-PN-200.110 as a specific ligand for VOC and 14C-DXR for CaM.
The effect of DXR on PKC
activity was evaluated by using HI-histone or protamine as substrate. DXR (Farmitalia-C.Erba, Milano) was from 0.05 to 0.6 mM.
tested at concentrations ranging
Here we focus the r-esutts obtained at the
concentration 0.1 mM, Which is
Of pharmacological interest because it
inhibits the contractility of isolated atria and
suppresses the fast
exchanging calcium pool (1). DXR 0.1 mM inhibits the PN-200.110 binding to
VOC by
16.31.
(mean
of
2
determinations)
(Fig.
ta):
Kd is
affected, While Bmax drops from 62.31 to 45.97 fmol/mg protein. activity
of
PKC is
inhibited
1043-6618/89/2110087--02/$03.00/0
by
26.05±3.67
1.
(Fig.
lb);
this
not The value
© 1989 The Italian Pharmacological Society
88
Pharmacological Research. Vol. 21. Supplement 1. 1989
corresponds to the effect observed when the enzyme operates either with
a
substrate
phosphatidilserine
requ iring
or
in
it s
the
absence.
presence The
of
former
calcium effect
and
is
the
consequence of the reported DXR-phospholipid competition (5), however here we show that DXR also exerts a direct inhibition on PKC. 1b
10
~8000
70
~7000 0..
PN
6000 ~5000
,, <10 t( ........ :50
~
c:
PN+OXR
~40
~4000
~JO u 20
~3000 '0
;2000 ,g 1000
f
f
0'"-------t.s 0 .0::1 0.5
10 0
1
100 200
~~ DXR does not appear to bind specifically to CaM.
400
eoc
~~ Taken together, the
literature data and the results of this study show that a concentrat ion on
of DXR of pllarmacological interest develops a multi-site action myocardial
structures bited; in
receptors
controlling
liv ing
cells
involved
both
the
inf lux
inhibi t ion
in
calc ium
and
efflux
of
the
t r ans por t, of
inf lux
whereby
calcium are
pr-eqommates,
inhisince
DXR brings about a diminution of the fast exchangeable calcium pool. REFERENCES Villani F, Picc inini F, Merelli P, Favall i L. Influence Adriamyc in on calcium exchangeability in card iac muscle and modifications by ouabain. Biochem Pharmacol 1976; 27:965-967. 1)
of its
2) Exton JH. Mechanisms of action of calcium-mob ilizing agonists: some variations on a young theme. FASEB J 1966; 2:2670-6. Caroni P, Villani F, Carafoli E. The card iotoxic antibiotic 3) Doxorubicin inhibits the Na/Ca exchange of dog heart sarcolemmal vesicles. FEBS Lett 1961; 130:164-6. 4) Tomlinson CW, Grodin DV, Rabkin SW. Adriamyc in cardiomyopathy: impli c a t ions with mild imp air men t of left ventr icular function. Biochem Pharmacol 1965; 34 :4033-41. 5) Palavoor- ST, Stein ST , Hait WN. Inhibition of protein kinase-C by antineoplastic agents: implications for drug resistance. stccnem stocnvs Res Commun 1967; 146:716-25.